A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)

PHASE2CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

January 31, 2015

Conditions
AlopeciaAlopecia, AndrogeneticBaldness
Interventions
DRUG

Bimatoprost Solution 1

Bimatoprost Solution 1 applied evenly onto pre-specified area on the scalp daily for 28 days, or daily for 6 months.

DRUG

Bimatoprost Solution 2

Bimatoprost Solution 2 applied evenly onto pre-specified area on the scalp daily for 28 days, or daily for 6 months.

DRUG

Bimatoprost Vehicle

Bimatoprost Vehicle (placebo) applied evenly onto pre-specified area on the scalp daily for 28 days, or daily for 6 months.

Trial Locations (1)

Unknown

Fridley

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01904721 - A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) | Biotech Hunter | Biotech Hunter